Our grant programs
Each year, we seek investigators and teams of investigators from around the world, with fresh ideas and the tools to study NETs in innovative ways. We offer four programs and a range of funding.
Areas of interest
Some areas of interest include but not limited to:
Application of existing or new technologies to target NETs
New/optimized experimental models
Deciphering the molecular underpinnings of NETs
Cell invasion and metastasis
Nuclear medicine, theranostics, imaging
We invite also proposals that cover promising and potentially transferable technologies, which have been applied successfully to other areas of cancer.
Organs of interest
While we recognize that neuroendocrine cancers can develop in many different organs, we exclusively focus on:
We continue to have an interest and fund applications proposing to study all aspects of gastro-entero-pancreatic NETs, including sites of metastasis.
We are interested in funding work in well differentiated, low-grade typical carcinoids (TCs), well-differentiated, intermediate-grade atypical carcinoids (ACs), or diffuse idiopathic neuroendocrine cell hyperplasia (DIPNECH).Currently, the lung fund does not extend to SCLC, LCLC, non-SCLC, squamous cell carcinomas, adenocarcinomas, mesotheliomas or poorly differentiated non–small cell lung carcinoms.
Areas for which we do not have specific funds right now, include NETs in organs such as brain, prostate, etc.
Expanding the field
Prior research in NETs is not a prerequisite. We encourage expert cancer scientists to enter the NET research field. However, such candidates must demonstrate a commitment to continue with NET research.